nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Carvedilol—VEGFA—head and neck cancer	0.0764	0.541	CrCbGaD
Methocarbamol—Nystagmus—Vinblastine—head and neck cancer	0.061	0.0711	CcSEcCtD
Methocarbamol—Nystagmus—Fluorouracil—head and neck cancer	0.04	0.0466	CcSEcCtD
Methocarbamol—Carvedilol—CYP1A1—head and neck cancer	0.0369	0.261	CrCbGaD
Methocarbamol—Propranolol—CYP1A1—head and neck cancer	0.028	0.198	CrCbGaD
Methocarbamol—Thrombophlebitis—Fluorouracil—head and neck cancer	0.024	0.0279	CcSEcCtD
Methocarbamol—Drowsiness—Hydroxyurea—head and neck cancer	0.0222	0.0259	CcSEcCtD
Methocarbamol—Amnesia—Fluorouracil—head and neck cancer	0.0221	0.0257	CcSEcCtD
Methocarbamol—Lightheadedness—Docetaxel—head and neck cancer	0.0185	0.0215	CcSEcCtD
Methocarbamol—Thrombophlebitis—Docetaxel—head and neck cancer	0.0173	0.0202	CcSEcCtD
Methocarbamol—Vertigo—Vinblastine—head and neck cancer	0.0171	0.0199	CcSEcCtD
Methocarbamol—Leukopenia—Vinblastine—head and neck cancer	0.0171	0.0199	CcSEcCtD
Methocarbamol—Convulsion—Vinblastine—head and neck cancer	0.0165	0.0192	CcSEcCtD
Methocarbamol—Conjunctivitis—Fluorouracil—head and neck cancer	0.0156	0.0181	CcSEcCtD
Methocarbamol—Leukopenia—Hydroxyurea—head and neck cancer	0.0156	0.0181	CcSEcCtD
Methocarbamol—Convulsion—Hydroxyurea—head and neck cancer	0.0151	0.0175	CcSEcCtD
Methocarbamol—Pain—Vinblastine—head and neck cancer	0.0133	0.0155	CcSEcCtD
Methocarbamol—Feeling abnormal—Vinblastine—head and neck cancer	0.0128	0.0149	CcSEcCtD
Methocarbamol—Somnolence—Hydroxyurea—head and neck cancer	0.0126	0.0147	CcSEcCtD
Methocarbamol—Dyspepsia—Hydroxyurea—head and neck cancer	0.0125	0.0145	CcSEcCtD
Methocarbamol—Pain—Hydroxyurea—head and neck cancer	0.0121	0.0141	CcSEcCtD
Methocarbamol—Vision blurred—Fluorouracil—head and neck cancer	0.0118	0.0137	CcSEcCtD
Methocarbamol—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0117	0.0136	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinblastine—head and neck cancer	0.0115	0.0133	CcSEcCtD
Methocarbamol—Jaundice—Docetaxel—head and neck cancer	0.0113	0.0131	CcSEcCtD
Methocarbamol—Conjunctivitis—Docetaxel—head and neck cancer	0.0112	0.0131	CcSEcCtD
Methocarbamol—Body temperature increased—Hydroxyurea—head and neck cancer	0.0112	0.0131	CcSEcCtD
Methocarbamol—Leukopenia—Fluorouracil—head and neck cancer	0.0112	0.013	CcSEcCtD
Methocarbamol—Convulsion—Fluorouracil—head and neck cancer	0.0108	0.0126	CcSEcCtD
Methocarbamol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0104	0.0122	CcSEcCtD
Methocarbamol—Confusional state—Fluorouracil—head and neck cancer	0.0103	0.012	CcSEcCtD
Methocarbamol—Dizziness—Vinblastine—head and neck cancer	0.0103	0.012	CcSEcCtD
Methocarbamol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0102	0.0119	CcSEcCtD
Methocarbamol—Vomiting—Vinblastine—head and neck cancer	0.00989	0.0115	CcSEcCtD
Methocarbamol—Headache—Vinblastine—head and neck cancer	0.00974	0.0113	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—head and neck cancer	0.00962	0.0112	CcSEcCtD
Methocarbamol—Hypotension—Fluorouracil—head and neck cancer	0.00954	0.0111	CcSEcCtD
Methocarbamol—Dizziness—Hydroxyurea—head and neck cancer	0.00938	0.0109	CcSEcCtD
Methocarbamol—Nausea—Vinblastine—head and neck cancer	0.00924	0.0108	CcSEcCtD
Methocarbamol—Insomnia—Fluorouracil—head and neck cancer	0.00923	0.0108	CcSEcCtD
Methocarbamol—Somnolence—Fluorouracil—head and neck cancer	0.00907	0.0106	CcSEcCtD
Methocarbamol—Vomiting—Hydroxyurea—head and neck cancer	0.00902	0.0105	CcSEcCtD
Methocarbamol—Dyspepsia—Fluorouracil—head and neck cancer	0.00898	0.0105	CcSEcCtD
Methocarbamol—Rash—Hydroxyurea—head and neck cancer	0.00894	0.0104	CcSEcCtD
Methocarbamol—Dermatitis—Hydroxyurea—head and neck cancer	0.00893	0.0104	CcSEcCtD
Methocarbamol—Headache—Hydroxyurea—head and neck cancer	0.00888	0.0103	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—head and neck cancer	0.00884	0.0103	CcSEcCtD
Methocarbamol—Pain—Fluorouracil—head and neck cancer	0.00873	0.0102	CcSEcCtD
Methocarbamol—Nausea—Hydroxyurea—head and neck cancer	0.00842	0.00981	CcSEcCtD
Methocarbamol—Feeling abnormal—Fluorouracil—head and neck cancer	0.00841	0.0098	CcSEcCtD
Methocarbamol—Urticaria—Fluorouracil—head and neck cancer	0.00811	0.00944	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—head and neck cancer	0.00809	0.00943	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—head and neck cancer	0.00808	0.00941	CcSEcCtD
Methocarbamol—Body temperature increased—Fluorouracil—head and neck cancer	0.00807	0.0094	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—head and neck cancer	0.00793	0.00924	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—head and neck cancer	0.00782	0.00911	CcSEcCtD
Methocarbamol—Hypersensitivity—Fluorouracil—head and neck cancer	0.00752	0.00876	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—head and neck cancer	0.00743	0.00865	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—head and neck cancer	0.00737	0.00858	CcSEcCtD
Methocarbamol—Shock—Docetaxel—head and neck cancer	0.00725	0.00844	CcSEcCtD
Methocarbamol—Pruritus—Fluorouracil—head and neck cancer	0.00722	0.00841	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—head and neck cancer	0.00688	0.00802	CcSEcCtD
Methocarbamol—Dizziness—Fluorouracil—head and neck cancer	0.00675	0.00786	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—head and neck cancer	0.00666	0.00776	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—head and neck cancer	0.00655	0.00763	CcSEcCtD
Methocarbamol—Vomiting—Fluorouracil—head and neck cancer	0.00649	0.00756	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—head and neck cancer	0.00648	0.00755	CcSEcCtD
Methocarbamol—Rash—Fluorouracil—head and neck cancer	0.00644	0.00749	CcSEcCtD
Methocarbamol—Dermatitis—Fluorouracil—head and neck cancer	0.00643	0.00749	CcSEcCtD
Methocarbamol—Headache—Fluorouracil—head and neck cancer	0.00639	0.00745	CcSEcCtD
Methocarbamol—Pain—Docetaxel—head and neck cancer	0.0063	0.00734	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—head and neck cancer	0.00607	0.00707	CcSEcCtD
Methocarbamol—Nausea—Fluorouracil—head and neck cancer	0.00606	0.00706	CcSEcCtD
Methocarbamol—Body temperature increased—Docetaxel—head and neck cancer	0.00582	0.00678	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—head and neck cancer	0.00543	0.00632	CcSEcCtD
Methocarbamol—Pruritus—Docetaxel—head and neck cancer	0.00521	0.00607	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—head and neck cancer	0.00487	0.00567	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—head and neck cancer	0.00468	0.00545	CcSEcCtD
Methocarbamol—Rash—Docetaxel—head and neck cancer	0.00464	0.00541	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—head and neck cancer	0.00464	0.0054	CcSEcCtD
Methocarbamol—Headache—Docetaxel—head and neck cancer	0.00461	0.00537	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—head and neck cancer	0.00438	0.0051	CcSEcCtD
